Atezolizumab
Atezolizumab market is segmented by region (country), players, by Type and by Application. Player ... Read More
Global and United States Pembrolizumab Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Pembrolizumab Product Introduction
1.2 Global Pembrolizumab Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pembrolizumab Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pembrolizumab Sales in Volume for the Year 2017-2028
1.3 United States Pembrolizumab Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pembrolizumab Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pembrolizumab Sales in Volume for the Year 2017-2028
1.4 Pembrolizumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pembrolizumab in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pembrolizumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pembrolizumab Market Dynamics
1.5.1 Pembrolizumab Industry Trends
1.5.2 Pembrolizumab Market Drivers
1.5.3 Pembrolizumab Market Challenges
1.5.4 Pembrolizumab Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pembrolizumab Market Segment by Type
2.1.1 50mg Injection
2.1.2 100mg Injection
2.2 Global Pembrolizumab Market Size by Type
2.2.1 Global Pembrolizumab Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pembrolizumab Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pembrolizumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pembrolizumab Market Size by Type
2.3.1 United States Pembrolizumab Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pembrolizumab Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pembrolizumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pembrolizumab Market Segment by Application
3.1.1 Advanced Melanoma
3.1.2 Head and Neck Squamous Cell Carcinoma (HNSCC)
3.1.3 Unresectable or Metastatic Solid Tumor
3.1.4 Other
3.2 Global Pembrolizumab Market Size by Application
3.2.1 Global Pembrolizumab Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pembrolizumab Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pembrolizumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pembrolizumab Market Size by Application
3.3.1 United States Pembrolizumab Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pembrolizumab Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pembrolizumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pembrolizumab Competitor Landscape by Company
4.1 Global Pembrolizumab Market Size by Company
4.1.1 Top Global Pembrolizumab Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pembrolizumab Revenue by Manufacturer (2017-2022)
4.1.3 Global Pembrolizumab Sales by Manufacturer (2017-2022)
4.1.4 Global Pembrolizumab Price by Manufacturer (2017-2022)
4.2 Global Pembrolizumab Concentration Ratio (CR)
4.2.1 Pembrolizumab Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pembrolizumab in 2021
4.2.3 Global Pembrolizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pembrolizumab Manufacturing Base Distribution, Product Type
4.3.1 Global Pembrolizumab Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pembrolizumab Product Type
4.3.3 Date of International Manufacturers Enter into Pembrolizumab Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pembrolizumab Market Size by Company
4.5.1 Top Pembrolizumab Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pembrolizumab Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pembrolizumab Sales by Players (2020, 2021 & 2022)
5 Global Pembrolizumab Market Size by Region
5.1 Global Pembrolizumab Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pembrolizumab Market Size in Volume by Region (2017-2028)
5.2.1 Global Pembrolizumab Sales in Volume by Region: 2017-2022
5.2.2 Global Pembrolizumab Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pembrolizumab Market Size in Value by Region (2017-2028)
5.3.1 Global Pembrolizumab Sales in Value by Region: 2017-2022
5.3.2 Global Pembrolizumab Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pembrolizumab Market Size YoY Growth 2017-2028
6.1.2 North America Pembrolizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pembrolizumab Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pembrolizumab Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pembrolizumab Market Size YoY Growth 2017-2028
6.3.2 Europe Pembrolizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pembrolizumab Market Size YoY Growth 2017-2028
6.4.2 Latin America Pembrolizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pembrolizumab Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pembrolizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck
7.1.1 Merck Corporation Information
7.1.2 Merck Description and Business Overview
7.1.3 Merck Pembrolizumab Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck Pembrolizumab Products Offered
7.1.5 Merck Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pembrolizumab Industry Chain Analysis
8.2 Pembrolizumab Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pembrolizumab Distributors
8.3 Pembrolizumab Production Mode & Process
8.4 Pembrolizumab Sales and Marketing
8.4.1 Pembrolizumab Sales Channels
8.4.2 Pembrolizumab Distributors
8.5 Pembrolizumab Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Pembrolizumab CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Pembrolizumab Market Trends
Table 3. Pembrolizumab Market Drivers
Table 4. Pembrolizumab Market Challenges
Table 5. Pembrolizumab Market Restraints
Table 6. Global Pembrolizumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pembrolizumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pembrolizumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pembrolizumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pembrolizumab Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Pembrolizumab Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Pembrolizumab Revenue Share by Manufacturer, 2017-2022
Table 13. Global Pembrolizumab Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Pembrolizumab Sales Share by Manufacturer, 2017-2022
Table 15. Global Pembrolizumab Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Pembrolizumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pembrolizumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pembrolizumab as of 2021)
Table 18. Top Players of Pembrolizumab in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Pembrolizumab Product Type
Table 20. Date of International Manufacturers Enter into Pembrolizumab Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Pembrolizumab Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Pembrolizumab Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Pembrolizumab Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Pembrolizumab Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Pembrolizumab Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Pembrolizumab Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Pembrolizumab Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Pembrolizumab Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Pembrolizumab Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Pembrolizumab Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Pembrolizumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Pembrolizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Pembrolizumab Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Pembrolizumab Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Pembrolizumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Pembrolizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Pembrolizumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Pembrolizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Pembrolizumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Pembrolizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Merck Corporation Information
Table 43. Merck Description and Business Overview
Table 44. Merck Pembrolizumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Merck Pembrolizumab Product
Table 46. Merck Recent Development
Table 47. Key Raw Materials Lists
Table 48. Raw Materials Key Suppliers Lists
Table 49. Pembrolizumab Customers List
Table 50. Pembrolizumab Distributors List
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Pembrolizumab Product Picture
Figure 2. Global Pembrolizumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pembrolizumab Market Size 2017-2028 (US$ Million)
Figure 4. Global Pembrolizumab Sales 2017-2028 (K Pcs)
Figure 5. United States Pembrolizumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Pembrolizumab Market Size 2017-2028 (US$ Million)
Figure 7. United States Pembrolizumab Sales 2017-2028 (K Pcs)
Figure 8. United States Pembrolizumab Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Pembrolizumab Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Pembrolizumab Report Years Considered
Figure 11. Product Picture of 50mg Injection
Figure 12. Product Picture of 100mg Injection
Figure 13. Global Pembrolizumab Market Share by Type in 2022 & 2028
Figure 14. Global Pembrolizumab Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Pembrolizumab Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Pembrolizumab Sales by Type (2017-2028) & (K Pcs)
Figure 17. Global Pembrolizumab Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Pembrolizumab Price by Type (2017-2028) & (USD/Pcs)
Figure 19. United States Pembrolizumab Market Share by Type in 2022 & 2028
Figure 20. United States Pembrolizumab Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Pembrolizumab Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Pembrolizumab Sales by Type (2017-2028) & (K Pcs)
Figure 23. United States Pembrolizumab Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Pembrolizumab Price by Type (2017-2028) & (USD/Pcs)
Figure 25. Product Picture of Advanced Melanoma
Figure 26. Product Picture of Head and Neck Squamous Cell Carcinoma (HNSCC)
Figure 27. Product Picture of Unresectable or Metastatic Solid Tumor
Figure 28. Product Picture of Other
Figure 29. Global Pembrolizumab Market Share by Application in 2022 & 2028
Figure 30. Global Pembrolizumab Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Pembrolizumab Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Pembrolizumab Sales by Application (2017-2028) & (K Pcs)
Figure 33. Global Pembrolizumab Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Pembrolizumab Price by Application (2017-2028) & (USD/Pcs)
Figure 35. United States Pembrolizumab Market Share by Application in 2022 & 2028
Figure 36. United States Pembrolizumab Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Pembrolizumab Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Pembrolizumab Sales by Application (2017-2028) & (K Pcs)
Figure 39. United States Pembrolizumab Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Pembrolizumab Price by Application (2017-2028) & (USD/Pcs)
Figure 41. North America Pembrolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 42. North America Pembrolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Pembrolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. Europe Pembrolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Pembrolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 53. Asia-Pacific Pembrolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Pembrolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 65. Latin America Pembrolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Pembrolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 70. Middle East & Africa Pembrolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Pembrolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Pembrolizumab Value Chain
Figure 75. Pembrolizumab Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck